
Biofrontera BFRI is gearing up to announce its quarterly earnings on Thursday, 2025-05-15. Here’s a quick overview of what investors should know before the release.
Analysts are estimating that Biofrontera will report an earnings per share (EPS) of $-0.29.
Biofrontera bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Here’s a look at Biofrontera’s past performance and the resulting price change:
Quarter | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
EPS Estimate | -0.83 | -0.77 | -1.17 | |
EPS Actual | -0.19 | -0.98 | -0.05 | -2.88 |
Price Change % | -17.0% | -15.0% | 2.0% | -10.0% |
Tracking Biofrontera’s Stock Performance
Shares of Biofrontera were trading at $0.7188 as of May 13. Over the last 52-week period, shares are down 37.61%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for Biofrontera visit their earnings calendar on our site.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.